Cytomegalovirus disease in adult marrow transplant recipients receiving ganciclovir prophylaxis: a retrospective study (vol 24, pg 665, 1999)

被引：0
|
作者：
Maltazou, H
机构：
来源：
BONE MARROW TRANSPLANTATION | 2000年 / 25卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：463 / 463
页数：1
相关论文
共 50 条
  • [1] Cytomegalovirus disease in adult marrow transplant recipients receiving ganciclovir prophylaxis: a retrospective study
    Maltazou, H
    Whimbey, E
    Abi-Said, D
    Przepiorka, D
    Champlain, R
    Goodrich, JM
    [J]. BONE MARROW TRANSPLANTATION, 1999, 24 (06) : 665 - 669
  • [2] Cytomegalovirus disease in adult marrow transplant recipients receiving ganciclovir prophylaxis: a retrospective study
    H Maltazou
    E Whimbey
    D Abi-Said
    D Przepiorka
    R Champlain
    JM Goodrich
    [J]. Bone Marrow Transplantation, 1999, 24 : 665 - 669
  • [3] Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies
    Said, T
    Nampoory, MRN
    Johny, K
    Pacsa, AS
    Abraham, PM
    Nair, MP
    Abdel-Haleem, M
    Samhan, M
    Al-Mousawi, M
    [J]. TRANSPLANTATION PROCEEDINGS, 2004, 36 (06) : 1847 - 1849
  • [4] Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients
    Canpolat, C
    Culbert, S
    Gardner, M
    Whimbey, E
    Tarrand, J
    Chan, KW
    [J]. BONE MARROW TRANSPLANTATION, 1996, 17 (04) : 589 - 593
  • [5] GANCICLOVIR PROPHYLAXIS TO PREVENT CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC MARROW TRANSPLANT
    GOODRICH, JM
    BOWDEN, RA
    FISHER, L
    KELLER, C
    SCHOCH, G
    MEYERS, JD
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 118 (03) : 173 - 178
  • [6] Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: Risk factors and outcome
    Salzberger, B
    Bowden, RA
    Hackman, RC
    Davis, C
    Boeckh, M
    [J]. BLOOD, 1997, 90 (06) : 2502 - 2508
  • [7] Effective oral ganciclovir prophylaxis against cytomegalovirus disease in heart transplant recipients
    Mullen, GM
    Silver, MA
    Malinowska, K
    Lawless, CE
    Lichtenberg, RC
    Barath, PC
    O'Keefe, PJ
    Robinson, JA
    Yeldandi, V
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (08) : 4110 - 4112
  • [8] Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis
    Akalin, E
    Sehgal, V
    Ames, S
    Hossain, S
    Daly, L
    Barbara, M
    Bromberg, JS
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (06) : 731 - 735
  • [9] Oral ganciclovir prophylaxis of cytomegalovirus (CMV) disease in pediatric renal transplant recipients.
    Feneberg, R
    Weber, LT
    Fickenscher, H
    Toenshoff, B
    [J]. PEDIATRIC TRANSPLANTATION, 2005, 9 : 118 - 118
  • [10] Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxis
    Nicholson, VA
    Whimbey, E
    Champlin, R
    AbiSaid, D
    Przepiorka, D
    Tarrand, J
    Chan, K
    Bodey, GP
    Goodrich, JM
    [J]. BONE MARROW TRANSPLANTATION, 1997, 19 (01) : 37 - 41
12345